In which wounds is an injectable hemostatic agent contraindicated?

Injection of hemostatic agents is contraindicated in abdominal and thoracic wounds due to the potential risk of causing additional complications. In cases involving these cavities, such as the abdomen or thorax, the introduction of a foreign substance can lead to serious adverse effects, including contamination of hollow organs, potential injury to internal structures, and exacerbation of bleeding or infection.

In the specific context of abdominal wounds, there are many vital organs and delicate structures. If an injectable hemostatic agent were to be administered incorrectly, it could interfere with surgical interventions or further complicate the patient's condition. The thoracic cavity has similar considerations, especially concerning the lungs and major blood vessels.

In contrast, other wounds listed—such as all deep tissue wounds, only abdominal wounds, or skin lacerations—may not present the same degree of risk if properly assessed and treated. However, an injectable hemostatic agent should be used judiciously based on the type of wound and clinical judgment, particularly avoiding scenarios that may compromise the patient’s safety.